Heart failure trials in China

In China 145 Also abroad 1261

145 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 4Taking people
The Effects of Ferric Derisomaltose in Patients With Acute Heart Failure and Iron Deficiency on Exercise Capacity and Quality of Life(COREVIVE-HFrEF)
Where
Beijing
Age
18 years and over
People
146
Run by
China-Japan Friendship Hospital
See details and how to joinNCT05971732
Phase 4Taking people
The Effects of Ferric Derisomaltose in Patients With Acute Heart Failure and Iron Deficiency on Exercise Capacity and Quality of Life
Where
Beijing
Age
18 years and over
People
170
Run by
China-Japan Friendship Hospital
See details and how to joinNCT05991128
Phase 4Taking people
SHengXIaN-QuYu DEcoction in Heart Failure With Reduced and Mildly Reduced Ejection Fraction
Where
Baoding, Beijing, Changji, Changzhi, Chengdu, Gongyi, Jining, Korla, Linhai, Qingdao, Qinhuangdao, Tianjin, Ürümqi, Xinyuan, Yangzhou, Yining, Zhaosu
Age
18 years and over
People
336
Run by
China-Japan Friendship Hospital
See details and how to joinNCT05583773
Phase 4Taking people
The Effects of Low-Dose Versus High-Dose Intravenous IRON Therapy With Ferric DerisomaltOSE in Patients With Chronic Heart Failure and Iron Deficiency
Where
Beijing
Age
18 years and over
People
114
Run by
China-Japan Friendship Hospital
See details and how to joinNCT06427343
No phaseTaking people
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Where
Beijing, Changsha, Dalian, Fuzhou, Guangzhou, Hangzhou, Harbin, Hefei, Kunming, Nanchang, Nanjing, Nanning, Shanghai, Shantou, Suining, Suzhou, Taiyuan, Tianjin, Ürümqi
People
20,000 worldwide
Run by
Medtronic
See details and how to joinNCT00271180
Phase 3Taking people
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Where
Beijing, Changchun, Changsha, Chifeng, Chongqing, Guangzhou, Haikou, Harbin, Hengyang, Heze, Jining, Lanzhou, Linhai, Luoyang, Nanning, Shenzhen, Taiyuan, Tianjin, Xuzhou, Yangzhou, Yuncheng, Zhengzhou
Age
18 years to 85 years
People
1,800 worldwide
Run by
Cytokinetics
See details and how to joinNCT06736574 · EU 2024-519219-32-00
No phaseTaking people
31P-MRS Myocardial Energetic Phenotyping and Prognosis Across the Cardiac Disease Spectrum
Where
Beijing
Age
18 years and over
People
1,000
Run by
Chinese Academy of Medical Sciences, Fuwai Hospital
See details and how to joinNCT07912086
No phaseTaking people
Vasopressor Agents in Pulmonary Hypertension Crisis
Where
Beijing, Guangzhou, Wuhan
Age
18 years and over
People
75
Run by
China National Center for Cardiovascular Diseases
See details and how to joinNCT07667829
Phase 3Taking people
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Where
Baotou, Beijing, Changchun, Changsha, Changzhou, Chengdu, Chifeng, Chongqing, Daqing, Guangzhou, Haikou, Hangzhou, Harbin, Hefei, Hengyang, Jinan, Kaifeng, Lishui, Luoyang, Nanchang, Nanjing, Pingxiang, Qinhuangdao, Shanghai, Shenyang, Shijiazhuang, Siping, Tai’an, Taiyuan, Tianjin, Wuhan, Wuxi, Xi'an, Xi’an, Yuncheng, Zhengzhou
Age
18 years to 99 years
People
5,056 worldwide
Run by
Amgen
See details and how to joinNCT07037459
Phase 3Taking people
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Where
Baotou, Beijing, Changchun, Changde, Changsha, Chengdu, Chenzhou, Dalian, Daqing, Deyang, Foshan, Fuzhou, Guangzhou, Guiyang, Haikou, Hangzhou, Harbin, Huainan, Jiangmen, Jinan, Jining, Lanzhou, Linfen, Luoyang, Nanchang, Nanjing, Nanning, Nanyang, Panjin, Pingxiang, Shanghai, Shengyang, Shenzhen, Shijiazhuang, Tianjin, Wenzhou, Wuhan, Xi'an, Xiangtan, Xinxiang, Xuancheng, Xuzhou, Yanji, Yinchuan, Yueyang, Yuncheng, Zhangjiakou, Zhengzhou, Zhenjiang
Age
18 years and over
People
6,712 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT06424288 · EU 2023-509706-30-00
Phase 3Taking people
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Where
Beijing, Changchun, Changde, Changsha, Chengdu, Chenzhou, Chongqing, Dalian, Daqing, Foshan, Fuzhou, Guangzhou, Guiyang, Haikou, Harbin, Jiangmen, Jinan, Lanzhou, Linfen, Luoyang, Nanchang, Nanjing, Nanning, Nanyang, Ningbo, Pingxiang, Shanghai, Shenyang, Shenzhen, Shijiazhuang, Tai’an, Taiyuan, Tianjin, Wuhan, Xi'an, Xinxiang, Xuancheng, Xuzhou, Yinchuan, Yueyang, Yuncheng, Zhangjiakou, Zhengzhou, Zhenjiang
Age
18 years and over
People
4,200 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT06935370 · EU 2024-519525-38-00
Phase 3Not yet taking people in China
Efficacy of Lipoic Acid on Chronic Ischemic Heart Failure Patients
Where
Dalian, Fuzhou, Guangdong, Guangzhou, Hangzhou, Hefei, Jinan, Jining, Luoyang, Nanjing, Qingdao, Quzhou, Shanghai, Taiyuan, Xi’an, Zhengzhou
Age
18 years to 75 years
People
1,188
Run by
Shanghai Zhongshan Hospital
See details and how to joinNCT07725484
No phaseNot yet taking people in China
Mobile Clinic-Supported, Village Doctor-Led Screening and Integrated Care for Atrial Fibrillation and Heart Failure Comorbidity in Rural China (MOVE-AF HF)
Where
Lianyungang
Age
65 years and over
People
1,200
Run by
Jiangsu Taizhou People's Hospital
See details and how to joinNCT07896863
No phaseTaking people
PRECISE-AFMR I: Transcatheter Mitral Valve Edge-to-Edge Repair for Atrial Functional Mitral Regurgitation in Patients at High Surgical Risk
Where
Beijing
Age
18 years and over
People
182
Run by
China National Center for Cardiovascular Diseases
See details and how to joinNCT07741253
Phase 2Taking people
A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
Where
Beijing, Changchun, Changsha, Guangzhou, Haikou, Hengyang, Jinan, Lanzhou, Shanghai, Shijiazhuang, Tianjin, Xi'an
Age
18 years to 79 years
People
620 worldwide
Run by
Pfizer
See details and how to joinNCT06991257 · EU 2024-518438-94-00
Phase 3Taking people
Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre
Where
Beijing, Bozhou, Changsha, Chengdu, Chifeng, Daqing, Dongguan, Fuzhou, Guangzhou, Hangzhou, Harbin, Hebi, Hefei, Hengyang, Heze, Huangshi, Jinan, Jining, Jinzhou, Kaifeng, Kunming, Lanzhou, Lishui, Liuzhou, Luoyang, Luzhou, Mianyang, Nanjing, Nanning, Panjin, Pingxiang, Puyang, Qingyang, Shanghai, Shenyang, Shijiazhuang, Shiyan, Suzhou, Taiyuan, Tangshan, Tianjin, Wuhan, Xi'an, Xi’an, Xianyang, Xingtai, Xinxiang, Yichang, Yulin, Yuncheng, Zhangjiakou
Age
18 years to 80 years
People
636
Run by
Tasly Pharmaceutical Group Co., Ltd
See details and how to joinNCT07687186
Phase 3Taking people
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Where
Baotou, Beijing, Changchun, Changde, Changsha, Changzhou, Chengdu, Chifeng, Chongqing, Guangzhou, Harbin, Hefei, Hengyang, Heze, Huangshi, Huizhou, Jinan, Jining, Kaifeng, Liaocheng, Linyi, Lishui, Luoyang, Meihekou, Nanchang, Nanjing, Nantong, Nanyang, Panjin, Pingxiang, Sanya, Shanghai, Shenyang, Siping, Suzhou, Taiyuan, Taizhou, Tianjin, Wenzhou, Wuhan, Xi'an, Xianyang, Xuzhou, Yinchuan, Zhumadian, Zigong
Age
40 years and over
People
11,300 worldwide
Run by
AstraZeneca
See details and how to joinNCT06677060 · EU 2024-514506-32-00
Phase 3Taking people
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
Where
Beijing, Binhai, Changchun, Changsha, Chongqing, Fuzhou, Guangzhou, Guiyang, Hangzhou, Harbin, Hefei, Jinan, Liaoning, Nanchang, Nanjing, Shanghai, Shanghaishi, Shijiazhuang, Taiyuan, Tianjin, Wuhan, Zhengzhou
Age
18 years and over
People
1,280 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07207811
No phaseTaking people
Cardiopulmonary Exercise Testing-based High-intensity Interval Training For Improving Heart Failure With Preserved Ejection Fraction
Where
Beijing, Qingdao, Shanghai, Wuhan
Age
35 years to 70 years
People
192
Run by
Peking University Third Hospital
See details and how to joinNCT07693049
No phaseTaking people
Screening Elderly Adults in Rural Communities for Heart Failure Using an NT-proBNP-Guided Strategy in China (SEARCH-HF)
Where
Nanjing
Age
65 years and over
People
2,532
Run by
Jiangsu Taizhou People's Hospital
See details and how to joinNCT07885488
No phaseTaking people
A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
Where
Fuzhou, Jinan, Nanjing, Xiamen
Age
18 years to 85 years
People
750 worldwide
Run by
Pulnovo Medical, Inc.
See details and how to joinNCT07214376
No phaseTaking people
The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)
Where
Jilin City, Shanghai
Age
18 years and over
People
754 worldwide
Run by
Sunnybrook Health Sciences Centre
See details and how to joinNCT05427370
No phaseNot yet taking people in China
Sequential Digital Intervention to Increase Influenza Vaccination in Patients With Heart Failure
Where
Ruyang
Age
18 years and over
People
588
Run by
Heart Health Research Center
See details and how to joinNCT07880158
Phase 3Taking people
Finerenone in Patients Undergoing Transcatheter Aortic Valve Implantation With Heart Failure
Where
Beijing, Bengbu, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Hefei, Jinan, Lanzhou, Nanjing, Ningbo, Qingdao, Shanghai, Shenyang, Tianjin, Ürümqi, Wenzhou, Wuhan, Xi’an, Zhengzhou
Age
65 years and over
People
2,832
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07575672
No phaseTaking people
SOCIAL_HF: Improving Social Frailty Through Interactive Learning
Where
Shanghai
Age
60 years and over
People
208
Run by
The University of Hong Kong
See details and how to joinNCT07234565